Literature DB >> 17251021

Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase.

I Wayne Cheney1, Shunqi Yan, Todd Appleby, Heli Walker, Todd Vo, Nanhua Yao, Robert Hamatake, Zhi Hong, Jim Z Wu.   

Abstract

A novel series of highly potent substituted pyridone Pim-1 kinase inhibitors is described. Structural requirements for in vitro activity are outlined as well as a complex crystal structure with the most potent Pim-1 inhibitor reported (IC(50)=50 nM). A hydrogen bond matrix involving the Pim-1 inhibitor, two water molecules, and the catalytic core, together with a potential weak hydrogen bond between an aromatic hydrogen on the R(1) phenyl ring and a main-chain carbonyl of Pim-1, accounts for the overall potency of this inhibitor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251021     DOI: 10.1016/j.bmcl.2006.12.086

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  32 in total

1.  Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

Authors:  Susann Herzog; Matthias Alexander Fink; Kerstin Weitmann; Claudius Friedel; Stefan Hadlich; Sönke Langner; Katharina Kindermann; Tobias Holm; Andreas Böhm; Eskil Eskilsson; Hrvoje Miletic; Markus Hildner; Michael Fritsch; Silke Vogelgesang; Christoph Havemann; Christoph Alexander Ritter; Henriette Elisabeth Meyer zu Schwabedissen; Bernhard Rauch; Wolfgang Hoffmann; Heyo Klaus Kroemer; Henry Schroeder; Sandra Bien-Möller
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

2.  Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agents.

Authors:  Mohamed A O Abdel-Fattah; Mahmoud A M El-Naggar; Rasha M H Rashied; Bernard D Gary; Gary A Piazza; Ashraf H Abadi
Journal:  Med Chem       Date:  2012-05       Impact factor: 2.745

3.  Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

Authors:  Mustapha Haddach; Jerome Michaux; Michael K Schwaebe; Fabrice Pierre; Sean E O'Brien; Cosmin Borsan; Joe Tran; Nicholas Raffaele; Suchitra Ravula; Denis Drygin; Adam Siddiqui-Jain; Levan Darjania; Ryan Stansfield; Chris Proffitt; Diwata Macalino; Nicole Streiner; Joshua Bliesath; May Omori; Jeffrey P Whitten; Kenna Anderes; William G Rice; David M Ryckman
Journal:  ACS Med Chem Lett       Date:  2011-12-27       Impact factor: 4.345

Review 4.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

5.  Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells.

Authors:  Hong Kyeung Kim; Chae Won Kim; Mai-Tram Vo; Hyun Hee Lee; Ji Young Lee; Nal Ae Yoon; Chae Yeong Lee; Chang Hoon Moon; Young Joo Min; Jeong Woo Park; Wha Ja Cho
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 6.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

7.  Ionic liquid-functionalized magnetic nanostructures as an efficient catalyst for the synthesis of 6H-chromeno[4,3-b]quinolin-6-ones.

Authors:  Golnaz Rahimzadeh; Saeed Bahadorikhalili; Ebrahim Kianmehr; Mohammad Mahdavi
Journal:  Mol Divers       Date:  2017-05-05       Impact factor: 2.943

8.  Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.

Authors:  Zuping Xia; Christian Knaak; Jian Ma; Zanna M Beharry; Campbell McInnes; Wenxue Wang; Andrew S Kraft; Charles D Smith
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

9.  Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.

Authors:  Ashraf H Abadi; Dalal A Abouel-Ella; Jochen Lehmann; Heather N Tinsley; Bernard D Gary; Gary A Piazza; Mohammed A O Abdel-Fattah
Journal:  Eur J Med Chem       Date:  2009-09-20       Impact factor: 6.514

10.  Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors.

Authors:  Ashraf H Abadi; Tamer M Ibrahim; Khaled M Abouzid; Jochen Lehmann; Heather N Tinsley; Bernard D Gary; Gary A Piazza
Journal:  Bioorg Med Chem       Date:  2009-07-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.